Suppr超能文献

氯氮平治疗迟发性肌张力障碍患者的精神病:三例报告。

Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases.

作者信息

Friedman J H

机构信息

Roger Williams Medical Center, Institute for Mental Health, Providence, Rhode Island 02908.

出版信息

Mov Disord. 1994 May;9(3):321-4. doi: 10.1002/mds.870090308.

Abstract

Among the tardive dyskinesia syndromes, dystonia can be the most difficult to treat. It may be severe to the point of being disabling, yet the patients may require antipsychotic medications for an even more disabling psychosis. Clozapine, an atypical neuroleptic drug that lacks extrapyramidal effects, may be the drug of choice for such patients. This report describes three patients with significant dystonia, previously disabled by their psychoses, who have been successfully managed with clozapine plus other agents for > 3 years.

摘要

在迟发性运动障碍综合征中,肌张力障碍可能是最难治疗的。它可能严重到致残的程度,但患者可能需要使用抗精神病药物来治疗更严重的致残性精神病。氯氮平是一种缺乏锥体外系效应的非典型抗精神病药物,可能是这类患者的首选药物。本报告描述了三名患有严重肌张力障碍的患者,他们之前因精神病而致残,使用氯氮平加其他药物成功治疗超过3年。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验